[go: up one dir, main page]

HRP20210323T1 - Pripravak za zaštitu od sunca - Google Patents

Pripravak za zaštitu od sunca Download PDF

Info

Publication number
HRP20210323T1
HRP20210323T1 HRP20210323TT HRP20210323T HRP20210323T1 HR P20210323 T1 HRP20210323 T1 HR P20210323T1 HR P20210323T T HRP20210323T T HR P20210323TT HR P20210323 T HRP20210323 T HR P20210323T HR P20210323 T1 HRP20210323 T1 HR P20210323T1
Authority
HR
Croatia
Prior art keywords
preparation
ala
agents
addition salt
acid addition
Prior art date
Application number
HRP20210323TT
Other languages
English (en)
Inventor
Ana SOLER
Trond Warloe
Qian Peng
Original Assignee
3Skin As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3Skin As filed Critical 3Skin As
Publication of HRP20210323T1 publication Critical patent/HRP20210323T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Claims (9)

1. Pripravak koji sadrži (a) 5-aminolevulinsku kiselinu (5-ALA) ili njenu kiselu adicijsku sol; (b) vitamin D3; i (c) UVA i / ili UVB zaštitno sredstvo, pri čemu je navedena 5-ALA ili njezina kisela adicijska sol prisutna u količini od 0.1 do 2.0 tež.% pripravka, i pri čemu je navedeni vitamin D3 prisutan u količini od 0.0001 do 0.005 tež.% pripravka.
2. Pripravak prema zahtjevu 1, naznačen time što je navedena 5-ALA ili njezina kisela adicijska sol prisutna u količini od 0.1 do 1.0 tež.% pripravka.
3. Pripravak prema zahtjevu 2, naznačen time što je navedena 5-ALA ili njezina kisela adicijska sol prisutna u količini od 0.1 do 0.5 tež.% pripravka.
4. Pripravak prema zahtjevu 1, naznačen time što je navedena 5-ALA ili njezina kisela adicijska sol prisutna u količini od 1 do 2 tež.% pripravka.
5. Pripravak prema bilo kojem od prethodnih zahtjeva, naznačen time što je navedena 5-ALA kisela adicijska sol hidrokloridna sol 5-aminolevulinske kiseline (ALA-HCl).
6. Pripravak prema bilo kojem od prethodnih zahtjeva, naznačen time što navedeni pripravak je pripravak za zaštitu od sunca i sadrži jedno ili više sredstava za kožnu zaštitu, konzervanse, pojačivače prodiranja kože, zgušnjivače, sredstava za modificiranje viskoznosti, gelirajuća sredstava, sredstava za odvajanje, sredstava za podešavanje pH, voskove , sredstva za sušenje, sredstva protiv svrbeži, sredstva protiv pjenjenja, pufere, sredstva za neutraliziranje, sredstva za bojenje, sredstva za promjenu boje, emulgatore, stabilizatore emulzije, mirise, antioksidante, razrjeđivače, nosače i / ili potisna goriva.
7. Pripravak prema bilo kojem od zahtjeva 1 do 6, naznačen time što se koristi u liječenju ili prevenciji aktinske keratoze.
8. Pripravak za uporabu prema zahtjevu 7, naznačen time što je navedena 5-ALA ili njezina kisela adicijska sol prisutna u količini od 0.1 do 1.0 tež.% pripravka.
9. Pripravak za uporabu prema zahtjevu 8, naznačen time što je navedena 5-ALA ili njezina kisela adicijska sol prisutna u količini od 0.1 do 0.5 mas.% pripravka.
HRP20210323TT 2017-02-06 2021-02-25 Pripravak za zaštitu od sunca HRP20210323T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20170179 2017-02-06
EP18704212.2A EP3576846B1 (en) 2017-02-06 2018-02-06 Sunscreen composition
PCT/EP2018/052949 WO2018141988A1 (en) 2017-02-06 2018-02-06 Sunscreen composition

Publications (1)

Publication Number Publication Date
HRP20210323T1 true HRP20210323T1 (hr) 2021-05-14

Family

ID=61189448

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20210323TT HRP20210323T1 (hr) 2017-02-06 2021-02-25 Pripravak za zaštitu od sunca

Country Status (15)

Country Link
US (2) US20200100997A1 (hr)
EP (2) EP3725374B1 (hr)
KR (1) KR20190112096A (hr)
CN (1) CN110325246B (hr)
AU (1) AU2018216043B2 (hr)
BR (1) BR112019015568B1 (hr)
CA (1) CA3051727A1 (hr)
CY (1) CY1123989T1 (hr)
DK (1) DK3576846T3 (hr)
ES (2) ES2981753T3 (hr)
HR (1) HRP20210323T1 (hr)
HU (1) HUE053510T2 (hr)
PL (1) PL3576846T3 (hr)
PT (1) PT3576846T (hr)
WO (1) WO2018141988A1 (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
EP3362145B1 (en) 2015-10-15 2021-01-06 DUSA Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
US10357567B1 (en) * 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
WO2020115102A1 (en) * 2018-12-05 2020-06-11 Repoceuticals Aps Compositions for use in the treatment of photosensitivity
US11756685B2 (en) * 2020-06-23 2023-09-12 L'oreal Ultraviolet light sensor and method to achieve targeted vitamin D levels
ES2956376A1 (es) * 2022-05-13 2023-12-20 Espada Regalado Jesus Uso de un procedimiento de transferencia fotonica secuencial para fomentar la fotoproteccion y regeneracion cutanea
WO2024215161A1 (ko) * 2023-04-13 2024-10-17 고려대학교 산학협력단 아연-포르피린 및 리그닌을 포함하는 자외선 차단용 화장료 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0133437A1 (en) * 1983-01-21 1985-02-27 Advanced Drug Technology Corporation Vitamin-containing skin care ointment
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
DE69613365T2 (de) 1995-03-10 2002-05-02 Photocure Asa, Oslo/Oslo Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
NO20002428D0 (no) * 2000-05-10 2000-05-10 Radiumhospitalets Forskningsst Hudpreparat
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
EP1313448B1 (en) * 2000-08-16 2010-04-07 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
JP2004175731A (ja) * 2002-11-28 2004-06-24 Noevir Co Ltd 老化防止用皮膚外用剤
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
WO2006039281A2 (en) * 2004-09-29 2006-04-13 Person John R Skin cancer prevention method and product
US20090130227A1 (en) * 2005-04-28 2009-05-21 Yoshiyasu Ito External preparation for skin
CN101217868A (zh) * 2005-05-10 2008-07-09 德米普瑟尔有限公司 用于皮肤护理的组合物和方法
WO2008106966A1 (en) * 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
CA2790827A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
WO2013092936A2 (en) * 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
WO2015091037A1 (en) * 2013-12-20 2015-06-25 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
KR102573972B1 (ko) * 2014-09-10 2023-09-01 워싱턴 유니버시티 전암성 피부 병변의 치료를 위한 조성물과 방법
KR20160141297A (ko) * 2015-05-29 2016-12-08 (주)클레어스코리아 피부 탄력에 효과를 갖는 마유를 함유하는 피부 재생용 화장료 조성물 및 이의 제조방법

Also Published As

Publication number Publication date
ES2981753T3 (es) 2024-10-10
CA3051727A1 (en) 2018-08-09
CY1123989T1 (el) 2022-05-27
EP3576846B1 (en) 2020-12-09
AU2018216043B2 (en) 2020-02-27
US20220313580A1 (en) 2022-10-06
US20200100997A1 (en) 2020-04-02
CN110325246A (zh) 2019-10-11
CN110325246B (zh) 2022-07-05
KR20190112096A (ko) 2019-10-02
EP3725374C0 (en) 2024-06-19
HUE053510T2 (hu) 2021-07-28
BR112019015568A2 (pt) 2020-03-17
EP3725374A1 (en) 2020-10-21
DK3576846T3 (da) 2021-03-01
EP3576846A1 (en) 2019-12-11
ES2859777T3 (es) 2021-10-04
EP3725374B1 (en) 2024-06-19
WO2018141988A1 (en) 2018-08-09
PL3576846T3 (pl) 2021-07-19
BR112019015568B1 (pt) 2023-03-28
AU2018216043A1 (en) 2019-08-29
PT3576846T (pt) 2021-03-09

Similar Documents

Publication Publication Date Title
HRP20210323T1 (hr) Pripravak za zaštitu od sunca
AR081789A1 (es) Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel
WO2015175986A3 (en) Keratin treatment formulations and methods
NZ743161A (en) Pet care cleansing composition
WO2015056216A3 (pt) Composição peptídica e respetivos usos
AR097599A1 (es) Una composición que comprende extracto de guaçatonga y aroeira, su uso y un método para la prevención y/o tratamiento de señales causadas por el envejecimiento de la piel
AR088056A1 (es) MODULACION DE TIMOSINA b-4 EN LA PIEL, METODO PARA MEJORAR EL ASPECTO ESTETICO DE LA PIEL, PARA TRATAR ARRUGAS, COMPOSICION COSMETICA
MX2018005786A (es) Formulaciones novedosas.
WO2015081904A3 (en) Polyurethaneurea solutions for compositions with active ingredients or fragrances
PH12018500910A1 (en) Novel method of use and compositions
WO2016177908A3 (fr) Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, acides ou ester, et la composition cosmetique les contenant
AR116997A1 (es) Composiciones antitranspirantes
MX2015008711A (es) Composicion cosmetica o dermatologica que comprende una merocianina y un agente de filtracion de los rayos ultravioleta a del tipo de 2-hidroxibenzofenona substituida con amino y/o un agente de filtracion de los rayos ultravioleta a organico, hidrofilico.
EP3662907C0 (en) ANTI-AGING OR SKIN REGENERATION COMPOSITION WITH PIPERONYL ACID AS ACTIVE INGREDIENT
JP2016074737A5 (hr)
CL2019000375A1 (es) Métodos y composiciones para reducir el encanecimiento del cabello
WO2017112996A8 (en) Cosmetic composition for moisturizing keratinic tissue
MY184483A (en) Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same
JP2017155062A5 (hr)
KR20120069198A (ko) 5-아미노레블린산 및 비타민씨 복합체를 함유하는 화장품 조성물
EP3158989A3 (en) Cosmetic skin treatment composition
EP3730130C0 (en) FORMULATION FOR ORAL ADMINISTRATION OF BLUEBERRY EXTRACT AS A CO-ADJUVANT FOR THE HEALTH OF THE HUMAN PRECORNEAL LAYER
CL2017002601A1 (es) Composición para formulación cosmética humectante de larga duración que comprende manteca de ucuuba (virola surinamensis), en una concentración de 1-5% del total de manteca y altas concentraciones de ácido mirístico así como su uso para la preparación de productos cosméticos (con efecto de tacto seco y pulverulento) con alta capacidad humectante y kit.
FR3074045B1 (fr) Composition cosmetique a l'extrait d'algue cystoseira tamariscifolia.
MX354866B (es) Composicion cosmetica o dermatologica que comprende una merocianina y un agente de filtro ultravioleta (uv) organico insoluble y/o un agente de filtro ultravioleta (uv) inorganico insoluble.